Latest Laboratory Equipment News

XRF Scientific has delivered its strongest September quarter in years, with revenue rising 38% to $21.1 million and profit before tax climbing 30% to $4.4 million. Orbis growth, resilient consumables demand and the developing CGA business are giving the company several avenues for further expansion, although precious metals revenue included a low-margin one-off sale.

Memphasys has signed a three-year exclusive distribution agreement covering the Czech Republic, Slovakia and Kazakhstan, with minimum purchases worth approximately A$674,000. The deal expands Felix’s European footprint while adding dedicated commercial leadership in the region.

Island Pharmaceuticals has expanded its partnership with USAMRIID to conduct a pivotal Galidesivir dose optimisation study against Marburg virus, targeting topline results in the second half of 2026.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Cleo Diagnostics has completed blood sample collection for its pivotal U.S. clinical trial, advancing its Pre-Surgical Ovarian Cancer Test closer to FDA submission.

Tolu Minerals Limited reports steady progress at its Tolukuma Gold Mine, advancing a major mine expansion project targeting 500 tonnes per day production by the first quarter of 2027. Key infrastructure developments, drilling expansion, and processing plant refurbishments underpin the company’s growth strategy.

Fortuna Metals has confirmed significant high-grade rutile mineralisation at its newly acquired Mkanda project in Malawi, supported by a successful A$3.5 million capital raise to advance exploration.

Lion Rock Minerals confirms coarse monazite crystals in residual soils at its Minta Est project, validating its exploration model and advancing its rare-earths ambitions. The milestone achievement also triggers the issuance of 500 million deferred shares to vendors.

Greenvale Energy’s maiden drilling at the Oasis Uranium Project delivers multiple high-grade uranium intercepts, while the company expands its tenure in the Northern Territory’s prolific Pine Creek region.

Cleo Diagnostics has successfully completed Stage 1 of the Medical Device Single Audit Program, marking a significant step toward FDA submission and global commercialisation of its ovarian cancer test.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million in FY25 but saw an 8.1% decline in underlying net profit after tax to $27.4 million, impacted by market softness and operational incidents. The company outlines cautious FY26 guidance amid ongoing sector headwinds.

XRF Scientific Limited reported a record profit for FY25, driven by strong mining sector demand and international sales growth, alongside strategic acquisitions that bolster its market position.